Prothena to Participate in Upcoming March Healthcare Conferences

Article Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 7/18/2026

1. NFLX
2. ISRG
3. SPY
4. AAPL
5. USB

6. NVDA
7. STT
8. SPCX
9. BA
10. GCTK

Get Alerts PRTA Hot Sheet

Price: $8.66 +2.24%

Overall Analyst Rating:
SELL (= Flat)

Revenue Growth %: +879.3%

Join SI Premium – FREE

DUBLIN, Ireland, March 05, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ: PRTA), a clinical-stage neuroscience company, today announced that members of its senior management team will present and participate in the following March investor conferences:

Barclays Global Healthcare Conference on March 12, 2019 at 8:30 AM ET in Miami, FL

Oppenheimer’s 29th Annual Healthcare Conference on March 20, 2019 at 1:35 PM ET in New York, NY

A live webcast of the company presentation can be accessed through the investor relations section of the Company's website at www.prothena.com. Following the live presentation, a replay of the webcast will be available on the Company's website for at least 90 days following the presentation date.

About Prothena

Prothena Corporation plc is a clinical-stage neuroscience company focused on the discovery and development of novel therapies with the potential to fundamentally change the course of progressive, life-threatening diseases. Fueled by its deep scientific understanding built over decades of neuroscience research, Prothena is advancing a pipeline of therapeutic candidates for a number of indications and novel targets including Parkinson’s disease and other related synucleinopathies (prasinezumab - PRX002/RG7935) and ATTR amyloidosis (PRX004), as well as tau, Aβ (Amyloid beta) and TDP-43 where its scientific understanding of disease pathology can be leveraged. For more information, please visit the Company's website at www.prothena.com and follow us on Twitter @ProthenaCorp.

Media and Investor Contact:

Ellen Rose, Head of Communications650-922-2405, [email protected]